Logo

Michael J. Fox Foundation

Erisyon Wins $189K Michael J. Fox Foundation Grant for Protein Biomarker Discovery

Erisyon will use its single-molecule protein sequencing technology to detect and validate biomarkers for early detection of Parkinson's disease.

New Parkinson's Disease RNA-Seq Dataset Enables Search for Disease Biomarkers
Premium

The Michael J. Fox Foundation-led project aims to lead researchers to new insights about biomarkers indicating Parkinson's disease progression.

NIH Launches Parkinson's Disease Research Partnership

The partnership includes biopharmaceutical, life science, and non-profit organizations, as well as several US government agencies.

Michael J. Fox Foundation Grants $4M to 23andMe for New Parkinson's Disease Collaboration

The study will provide researchers, drugmakers, regulators, and payors with insight into the genetics of the disease and experience of the patients.

GNS Healthcare's Machine Learning Platform Leads to Novel Parkinson's Gene Discovery
Premium

Using data from the Parkinson's Progression Markers Initiative, GNS Healthcare identifies genetic and molecular markers of rapid motor progression.

Apr 12, 2016

STSI Launches Study to Improve Screening Accuracy for Parkinson's Disease
Premium

Oct 3, 2014

Michael J. Fox Foundation Funds GVSU Research into Parkinson's Biomarker

Jun 27, 2012

KineMed Receives $1.2M from Michael J. Fox Foundation for Parkinson's Biomarkers

Jan 25, 2012

Lucigen Receives $187K Grant from Michael J. Fox Foundation

Jun 24, 2011

23andMe-Led Team Reports on Findings from Web-Based Parkinson's GWAS

Jun 3, 2011

Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
Premium

Jul 6, 2010

Michael J. Fox Foundation Gives $1.1M for Parkinson's Biomarker Development

Oct 1, 2009

Sigma-Aldrich to Develop Parkinson's Models

Mar 18, 2009

Snippets: Mar 18, 2009
Premium

Mar 17, 2009

Short Reads: Mar 17, 2009
Premium

Mar 13, 2009

23andMe-Led Team Offers Program to Enroll Parkinson's Patients

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.